Free tools, free alerts. Create a free account to get sector-matched alerts and save your searches.
Create free account →
NAFDAC is intensifying regulatory oversight through new clinical trial training requirements, blacklisting of foreign suppliers, and watchlisting of local distributors, while also expanding its pharmacist reserve corps. For Nigerian SMBs in pharmaceuticals, healthcare, and related distribution, this means stricter compliance obligations and heightened supply chain scrutiny. Businesses should verify supplier and product statuses and prepare for mandatory training and potential disruptions.
Pharmaceuticals
Healthcare
Import/Distribution
Clinical Research
Food and Drug
Export/Agriculture
NAFDAC and NHREC Announce New Dates for Mandatory Stakeholders Training on Clinical Trial Regulations in Nigeria
NAFDAC
NAFDAC and NHREC have rescheduled mandatory training on clinical trial regulations for stakeholders in Nigeria.
SMBs involved in clinical trials or research must ensure their staff attend the training to remain compliant; failure could delay or halt trial activities.
Public Notice on Blacklisting Ayrtons Saunders Ltd, UK
NAFDAC
NAFDAC has blacklisted Ayrtons Saunders Ltd, UK, and its products, warning importers, distributors, and healthcare institutions to avoid them.
SMBs importing or distributing products from this company must immediately cease and verify their supply chains to avoid regulatory penalties and product seizures.
Public Alert No. 043/2026: NAFDAC Places Products Marketed by Mofus Nigeria Ltd on Watchlist
NAFDAC
NAFDAC has placed products marketed by Mofus Nigeria Ltd on a watchlist pending regulatory investigation.
Retailers, wholesalers, and PPMVs dealing with Mofus products should suspend sales and cooperate with investigations to avoid sanctions.
Inauguration Ceremony of the NAFDAC Pharmacist Reserve Group
NAFDAC
NAFDAC inaugurated 600 pharmacists into a voluntary reserve group to support regulatory activities.
SMBs may benefit from increased regulatory support and faster processing, but also expect more inspections and enforcement from reserve pharmacists.
Address by Prof. Mojisola Christianah Adeyeye at the 49th Annual International Conference of the Chemical Society of Nigeria
NAFDAC
NAFDAC DG highlighted innovations in medicinal and pharmaceutical chemistry for affordable healthcare delivery.
SMBs in pharmaceutical manufacturing and research should align with innovation trends and potential regulatory shifts toward affordable healthcare.
NDLEA, NAFDAC exempted from dissolution of FG parastatals boards
NAFDAC
NAFDAC and NDLEA were exempted from the dissolution of federal parastatal boards, ensuring continuity in leadership.
This stability means ongoing regulatory frameworks remain in place, providing predictability for SMBs dealing with NAFDAC.
How to Register Your Fish Farm with NEPC Nigeria: A Complete Export Guide
Other
A guide on registering fish farms with NEPC for export purposes.
SMBs in aquaculture and fish farming can leverage this guide to access export markets, but must comply with NEPC registration requirements.
Increased regulatory scrutiny on pharmaceutical imports and distribution
Mandatory training for clinical trial stakeholders may create compliance burden
Blacklisting and watchlisting of suppliers could disrupt supply chains
Expansion of NAFDAC pharmacist reserve may lead to more frequent inspections
Focus on affordable healthcare innovation may open opportunities for local manufacturers
Export opportunities for fish farmers through NEPC registration
1
Verify that your suppliers and products are not blacklisted or watchlisted by NAFDAC
2
Register for and attend the mandatory clinical trial regulations training if involved in trials
3
Review and update your import and distribution procedures to align with NAFDAC alerts
4
Ensure your staff are aware of NAFDAC's pharmacist reserve group and cooperate with inspections
5
For fish farmers, initiate NEPC registration to access export markets
6
Monitor NAFDAC announcements regularly for updates on regulations and alerts